A phase Ib/II Study of Palbociclib in Combination with Bazedoxifene in Hormone Receptor Breast Cancer
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP371535
下载链接
链接失效反馈官方服务：
资源简介：
In this phase Ib/II clinical trial, the investigators evaluated the efficacy and safety of the combination of palbociclib with bazedoxifene in patients with a metastatic endocrine-resistant hormone receptor-positive, HER2-negative breast cancer. Furthermore, whole exome sequencing of cell-free tumor DNA was done on serial samples from these patients, revealing potential molecular changes associated with mechanisms of resistance.
创建时间：
2022-12-16
